Shionogi Inc. is the U.S. based company of Shionogi & Co., Ltd., a leading Japanese pharmaceutical company. Established in 1878, Shionogi & Co., Ltd. is based in Osaka, Japan. The company has a distinguished history in developing innovative therapies that address unmet medical needs. With its core business of ethical pharmaceuticals, Shionogi & Co., Ltd. has a strategic focus in infectious diseases, oncology, women's health, HIV, cardiovascular and metabolic diseases, and chronic pain.
Shionogi & Co., Ltd. employs more than 6,000 people worldwide and reported revenue of approximately $3.4 billion at the end of fiscal year 2012. As part of its ongoing commitment to research, the company invested approximately $680 million in R&D.
This story of growth and innovation is anchored in the corporate mission to "constantly strive to produce superior medicine essential to people's health". Since its inception when Gisaburo Shiono founded a drug wholesaling business in Osaka, Shionogi & Co. Ltd. has lived this vision in the way it does business. Even the company logo, the Fundoh (pronounced "foon-do"), a Japanese symbol of the scale weight in dispensing products, continues to reflect a commitment to operational excellence and accuracy.
In 2010, Shionogi Inc. was established as the U.S. headquarters. Based in Florham Park, New Jersey the company oversees commercial and R&D activities that take place in the U.S. Led by CEO John Keller, Shionogi Inc. has fully integrated capabilities that span clinical development, regulatory affairs, and commercialization. The U.S. operations are a key component of Shionogi & Co., Ltd. global strategy, complementing the research labs in Japan with the ability to independently develop and market products in the U.S.
Shionogi Inc.'s marketed products in the U.S. cover a range of clinical areas including pain, pediatrics, and cardiovascular/diabetes. A robust pipeline expands the therapeutic portfolio to include allergies, oncology, anti-infectives, women's health, and HIV. Ospemifene, a first of its kind drug in women's health, is expected to receive FDA approval in the first quarter of this year.
Shionogi Inc. combines the entrepreneurial spirit and commercial nimbleness of a specialty pharmaceutical company with the expertise and stability of an established global company. It is the best of both worlds in values and product excellence.
Shionogi Inc. is a values driven company spurred by the vision of making a difference in people's lives. The performance based culture is marked by innovation, transparency, and speed of execution. We take pride in delivering the highest quality products and services and always exceeding customers' expectations.
Our values are as enduring and long-standing as our company history:
- Entrepreneurial Spirit
- Transparent Communications
- Organizational Alignment
- Performance Driven
- Operational Excellence
Shionogi Inc. is a financially strong company with established products and a robust pipeline. Most recently the company was cited as an "Emerging Business of the Year" finalist, a major recognition of success in the early years of U.S. operations. Ours is a story with a great past and an even more exciting future.
We can only accept resumes of candidates who submit their resumes through our on-line postings.
Shionogi Inc. is an equal opportunity employer EEO/AA and strongly supports diversity in the workplace, and all qualified applicants will receive consideration without regard to race, age, color, religion, sex, or national origin, status as a qualified individual with a disability or Vietnam era of other protected veteran. M/F/V/D
Search open positions >